(Total Views: 648)
Posted On: 11/11/2020 2:04:21 PM
Post# of 148936
COVID IS KILLING THOUSANDS> Fill the Trial. Fill the Trial. Fill the Trial. Just FILL THE TRIAL. Who cares what the price is today. Trade, invest, speculate, sell short, pontificate from sidelines.
JUST FILL THE DARN TRIAL. There are 43,000 investor/advocates!
Novel Drug Leronlimab has FDA-Approved Phase 3 Clinical Trials for Near Death COVID-19 Patients Filling Up as Infections and Deaths Soar.
FDA COVID Severe/Critical Clinical Trial Data for Leronlimab: https://clinicaltrials.gov/ct2/show/NCT04347239FDA COVID Severe/Critical Clinical Trial Sites for Leronlimab:
https://www.cytodyn.com/clinical-trial-enroll...r-critical
New Drug for Near-Death COVID-19 Patients in Seeking FDA Approval with Over 300,000 Doses of Leronlimab in Stock, 800K More Being Made CytoDyn, Inc This Year.
Samsung Biologics Manufacturing Leronlimab for COVID-19 Treatment (08/19/20 update)https://www.cytodyn.com/clinical-trial-enrollment/covid-19-severe-or-critical
Novel New Drug Leronlimab for Near Death COVID-19 Patients Seeks Approval Assistance from both Trump Administration and Biden Transition Team
Novel Drug Leronlimab Shows Positive Data for Near-Death Covid Patients: 195 patients in Phase 2/3 Clinical Trial Interim Data, 63 patients in Right-to-Try Case Data and 10 patients in Int. Journal of Infectious Disease paper Mechanism of Action.
Positive Phase 2/3 DSMC Recommendation https://www.cytodyn.com/investors/news-events...er-interim
"Given the role of CCR5 in immune cell migration and inflammation, we investigated the impact of CCR5 blockade via the CCR5-specific antibody leronlimab on clinical, immunological and virological parameters in patients with severe COVID-19 disease. "
https://www.sciencedirect.com/science/article...1220323055
JUST FILL THE DARN TRIAL. There are 43,000 investor/advocates!
Novel Drug Leronlimab has FDA-Approved Phase 3 Clinical Trials for Near Death COVID-19 Patients Filling Up as Infections and Deaths Soar.
FDA COVID Severe/Critical Clinical Trial Data for Leronlimab: https://clinicaltrials.gov/ct2/show/NCT04347239FDA COVID Severe/Critical Clinical Trial Sites for Leronlimab:
https://www.cytodyn.com/clinical-trial-enroll...r-critical
New Drug for Near-Death COVID-19 Patients in Seeking FDA Approval with Over 300,000 Doses of Leronlimab in Stock, 800K More Being Made CytoDyn, Inc This Year.
Samsung Biologics Manufacturing Leronlimab for COVID-19 Treatment (08/19/20 update)https://www.cytodyn.com/clinical-trial-enrollment/covid-19-severe-or-critical
Novel New Drug Leronlimab for Near Death COVID-19 Patients Seeks Approval Assistance from both Trump Administration and Biden Transition Team
Novel Drug Leronlimab Shows Positive Data for Near-Death Covid Patients: 195 patients in Phase 2/3 Clinical Trial Interim Data, 63 patients in Right-to-Try Case Data and 10 patients in Int. Journal of Infectious Disease paper Mechanism of Action.
Positive Phase 2/3 DSMC Recommendation https://www.cytodyn.com/investors/news-events...er-interim
"Given the role of CCR5 in immune cell migration and inflammation, we investigated the impact of CCR5 blockade via the CCR5-specific antibody leronlimab on clinical, immunological and virological parameters in patients with severe COVID-19 disease. "
https://www.sciencedirect.com/science/article...1220323055
(5)
(0)Scroll down for more posts ▼
